- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Shimadzu debuts two new ultrasound systems
Displayed in 1999 as a work-in-progress, Shimadzu's SDU-2200 will be shown as a finished product at this year's RSNA meeting. A new version of the SDU-450, the SDU-450 XL, will also be introduced.The SDU-2200 system includes 3-D, tissue harmonic imaging,
Displayed in 1999 as a work-in-progress, Shimadzu's SDU-2200 will be shown as a finished product at this year's RSNA meeting. A new version of the SDU-450, the SDU-450 XL, will also be introduced.
The SDU-2200 system includes 3-D, tissue harmonic imaging, and DICOM connectivity. Its proprietary digital electronics provide high-speed parallel processing, a quad digital beamformer, and high-level digital noise suppression. The SDU-2200 is a multipurpose, shared services system with applications that include cardiac, vascular, abdominal, ob/gyn, and urology.
The SDU-1200 uses the same console, operating system, and digital electronics as the SDU-2200. Applications are vascular, abdominal, ob/gyn, and urology, and its intended markets are outpatient centers and large private practices.
Both systems are semiautomatic and suitable for mobile applications.
The new SDU-450 XL includes an upgraded CPU with faster processing and enhanced applications software for ob/gyn, urology, emergency medicine, and family practice.
Shimadzu Ultrasound systems include Shimadzu's Truevision broadband probe technology with frequency versatility of 2 to 15 MHz.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
